Autotaxin–lysolipid signaling suppresses a CCL11–eosinophil axis to promote pancreatic cancer progression
2024 · Nature Cancer · 34 citations
https://doi.org/10.1038/s43018-023-00703-y
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
18
Papers
221
Citations
4
h-index
4
i10-index
Holly Sandborg is an academic researcher from Memorial Sloan Kettering Cancer Center. The author has contributed to research in topics: Lung Cancer Research Studies & Immune cells in cancer & Peptidase Inhibition and Analysis. The author has an h-index of 4, co-authored 16 publications.
ORCID: 0000-0003-1342-3136Click to start Chat